J. Read

Seriosity, Inc. develops enterprise software applications. It also provides consulting, development and deployment services. The company was founded by Byron Reeves and Leighton J. Read in 2004 and is headquartered in Palo Alto, CA.

Apptera, Inc. provides technology for mobile advertising, search and commerce. It provides real-time call handling solutions that are supported by audio advertising. The firm is a mobile communications and advertising company with a newly launched free app called Raved, may turn that quest into reality-or at least a nice chunk of change. The company was founded in 2001 by Leo King-Yin Chiu and is headquartered in Sunnyvale, CA.

Siluria Technologies, Inc. develops and manufactures a direct chemical process for plastics and fuels from natural gas. Its second process technology can convert ethylene to liquid fuels such as gasoline, diesel or jet fuel. The firm’s revolutionary catalyst technologies uniquely combine nanomaterials, biotechnology and chemical engineering, to convert an abundant, ubiquitous, and inexpensive feedstock into high value, drop-in fuels and chemicals using processes that can be seamlessly integrated into existing industry infrastructure. The company was founded by Clinton Whitewood Bybee and Alexander Tkachenko in 2007 and is headquartered in San Francisco, CA.

Institute for Systems Biology operates as a nonprofit biomedical research organization. It develops a systems approach to characterize, predict, and manipulate state transitions in biological system. The company was founded by Leroy E. Hood, Ruedi Aebersold and Alan Aderem in 2000 and is headquartered in Seattle, WA.

University of California, Berkeley Foundation engages in the provision of philanthropic services.It offers social services and supports the advancement of higher education by securing private financial support. The company was founded by Phoebe Apperson Hearst, Jane Sather, Charles Franklin Doe in 1868 and is headquartered in Berkeley, CA.

Santa Fe Institute of Science operates as a nonprofit, independent research center. It provides research and education services. The company was founded by George Cowan, David Pines, Stirling Colgate, Murray Gell-Mann, Nick Metropolis, Herb Anderson, Peter A. Carruthers, and Richard Slansky in May 1984 and is headquartered in Santa Fe, NM.

Beneficent Technology, Inc. is a nonprofit organization that develops software for social good. The non-profit company is based in Palo Alto, CA. The company's software empowers communities and benefits all of humanity. The company was founded by James R. Fruchterman. Betsy Beaumon has been the CEO of the company since 2018.

GI Therapies Pty Ltd. designs and develops medical devices for the treatment of chronic constipation. It offers technology to treat gastrointestinal motility disorders, including chronic constipation, irritable bowel syndrome with constipation and gastroparesis. The company was founded in 2012 and is headquartered in Melbourne, Australia.

Global Kinetics Pty Ltd. provides point of care measurement and reporting of Parkinson's disease motor symptoms. Its product includes Personal KinetiGraph (PKG), a wrist worn medical device which reminds the patient when they have taken Levodopa medication as prescribed by doctor. The company was founded by Robert Griffiths and Malcolm Horne in 2007 and is headquartered in Melbourne, Australia.

Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia.

BioPlus Acquisition Corp. is an early stage blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It focuses on identifying an opportunity in the life sciences industry. The company was founded on February 11, 2021 and is headquartered in New York, NY.

Foundry Therapeutics 1, Inc. engages in the development of pharmaceutical products. The company is headquartered in Menlo Park, CA.

Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA.

CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases